Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Mechanism of Action Tirzepatide acts by activating both: GIP receptors GLP-1 receptors This dual incretin activity helps to: Increase glucose-dependent insulin secretion Reduce glucagon secretion during hyperglycemia Delay gastric emptying Increase satiety and reduce caloric intake Promote clinically meaningful weight loss Improve insulin sensitivity indirectly through weight reduction Clinical Benefits When used as prescribed alongside lifestyle modification, MOUNJARO may help: Improve HbA1c levels Lower fasting and post-meal blood glucose Promote substantial body weight reduction Improve insulin sensitivity Reduce appetite and food intake Support long-term glycemic control Improve several cardiometabolic risk factors through weight reduction Clinical benefits vary among individuals
The FDA label, and therefore the insurance coverage, was not
Individual timelines vary based on factors like stomach sensitivity, baseline metabolic rate, and whether you've used GLP-1 medications before
Retrieved from: Rueger, A
US$ 28.43
US$ 22.32
US$ 29.31
US$ 20.48
